Our Partners
GNS has partnered with the following organizations and companies:
CombinatoRx
Area: Discovery of mechanisms of synergy for combination therapies
The Jackson Laboratory
Area: Metabolic disease
Johnson & Johnson
Area: Receptor Tyrosine Kinase inhibitor drug candidates for cancer
H. Lee Moffitt Cancer Center & Research Institute
Area: Cancer disease mechanisms
Novartis
Area: Drug toxicity
"An integrated approach for inference and mechanistic modeling for advancing drug development"
Sergej V. Aksenov, Bruce Church, Anjali Dhiman, Anna Georgieva, Ramesh Sarangapani, Gabriel Helmlinger, Iya G. Khalil, FEBS Letters (2005).
Pfizer
Areas: Multiple
University of Budapest
Area: Oncology drug resistance mechanisms
University of California, San Francisco
Area: Cancer signaling pathways
Weill Cornell Medical School
Area: Discovery of mechanisms of synergy for combination therapies FTIs and taxanes